A naukri.com initiative
Bioengineer
7d
248
Image Credit: Bioengineer
NIH to Spearhead Implementation of National Plan to Combat Parkinson’s Disease
- The Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act, signed into law on July 2, 2024, will be led by the National Institutes of Health to address Parkinson’s disease.
- The act establishes a Federal Advisory Council on Parkinson’s Research, Care, and Services to facilitate collaboration in the fight against Parkinson’s disease and related disorders.
- The objectives of the act include enhancing Parkinson’s-related research coordination, improving early diagnosis, and smoothing the care continuum for patients.
- The strategy focuses on addressing the mental, physical, and social health effects of Parkinson’s on individuals and their families, recognizing that caregivers play a crucial role.
- By including a family caregiver on the advisory council, the NIH seeks to ensure that recommendations made to NIH are well-informed and actionable.
- Representatives from 13 federal agencies will take part in the advisory council, contributing to the breadth of knowledge and expertise available.
- International coordination is a crucial goal of the act, facilitating a shared global understanding of Parkinson’s disease through increased communication and collaboration.
- The NIH aims to pool resources and foster open communication among various entities to usher in a new era of understanding and addressing Parkinson’s disease.
- The act represents a significant advancement in the fight against neurodegenerative disorders.
- It is a comprehensive strategy that recognizes the complexities of Parkinson’s and aims to address them through a multifaceted, coordinated approach.
Read Full Article
14 Likes
For uninterrupted reading, download the app